Delivery Order SPE2DB22D1106-SPE2DB25FFEC6
- Not listed
- This is a $1,819.91 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,908,914 units of Vitamin D2 1.25mg (50,000 unit) tablets. The award has an ultimate completion date of April 15, 2025 and was made on April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
- This federal contract award, valued at $8,401.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vitamin D2 1.25mg (50,000 unit) tablets, to be completed by December 30, 2024. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a $9,677.13 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Vitamin D2 1.25 mg (50,000 unit) tablets, and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,245.00, is for the delivery of Vitamin D2 1.25mg tablets (4567306625 ! VIT D2 1.25MG 100S) with a period of performance through March 18, 2025. The contract is a Delivery Order under Firm Fixed Price terms. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,443.68 firm fixed-price delivery order is for the supply of vitamin D2 (1.25 mg, 50,000 units) in 100-count containers. The award does not have a set-aside designation. The contract has an ultimate completion date of September 23, 2024 and was awarded on September 20, 2024. Amerisourcebergen holds a large Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100,000 units of Vitamin D2 1.25mg (50,000 unit) tablets, with a total ceiling value of $1,044. The contract is a firm-fixed-price, delivery order type, with a performance period ending on June 5, 2024. The contract was not set aside for any specific business category. This award...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,776.33 firm fixed-price delivery order is for the supply of VITAMIN D2 1.25MG (50,000 UNIT) 100S. The award has an ultimate completion date of April 9, 2025. No set-aside designation was used. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,822.59 firm fixed price delivery order is for the supply of 4,566,554,652 units of Vitamin D2 1.25MG (50,000 unit) in 100-count bottles. The contract has a performance period through November 27, 2024 and was awarded on November 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Vitamin D3 400 IU/mL pharmaceutical supply with a ceiling value of $1,468.80. This firm fixed-price delivery order, which falls under a non-competitive set-aside, is scheduled for completion by October 2, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,546.59, is for the delivery of Vitamin D2 1.25MG (50,000 unit) in 100-count bottles. The contract is a Delivery Order and has a Firm Fixed Price pricing type, with a completion date of December 5, 2024. This contract does not have a set-aside designation, indicating open competition....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFEC6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vitamin D2 1.25mg (50,000 unit) tablets in quantities of 100 per unit, with a ceiling value of $26,081.28. This firm fixed-price delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract vehicle enables the company to fulfill federal medical procurement needs across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 8/19/25 |